Arsenic and diabetes: Current perspectives

Kaohsiung Journal of Medical Sciences

Volumn 27, Issue 9, 2011, Pages 402-410

  Huang, Chun Fa ^a   Chen, Ya Wen ^b   Yang, Ching Yao ^c   Tsai, Keh Sung ^c   Yang, Rong Sen ^d   Liu, Shing Hwa ^c  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Arsenic; Diabetes mellitus; Epidemiological studies; Experimental studies

Indexed keywords

ARSENIC; DRINKING WATER; INORGANIC COMPOUND;

ARSENIC POISONING; COMMUNITY ASSESSMENT; DIABETES MELLITUS; DIABETOGENESIS; DISEASE ASSOCIATION; EXPOSURE; GLUCOSE TRANSPORT; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INSULIN RELEASE; LONG TERM EXPOSURE; NON INSULIN DEPENDENT DIABETES MELLITUS; OCCUPATIONAL TOXICOLOGY; POPULATION RESEARCH; PREVALENCE; REVIEW; URINALYSIS;

ARSENIC; ARSENIC POISONING; BANGLADESH; DIABETES MELLITUS; HUMANS; TAIWAN;

EID: 80052692672     PISSN: 1607551X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.kjms.2011.05.008     Document Type: Review

References (73)

1. D.K. Nordstrom Public health. Worldwide occurrences of arsenic in ground water Science 296 2002 2143 2145
2. Agency for Toxic Substances and Disease Registry Toxicological profile for Arsenic U.S., Department of Health and Human Services, Public Health Service, Agency for Toxic Substances and Disease Registry, Atlanta, GA 2007 1 3
3. S. Otles, and O. Cagindi Health importance of arsenic in drinking water and food Environ Geochem Health 32 2010 367 371
4. V.M. Rodriguez, M.E. Jimenez-Capdeville, and M. Giordano The effects of arsenic exposure on the nervous system Toxicol Lett 145 2003 1 18 (Pubitemid 38366125)
5. J.M. Chiou, S.L. Wang, C.J. Chen, C.R. Deng, W. Lin, and T.Y. Tai Arsenic ingestion and increased microvascular disease risk: observations from the south-western arseniasis-endemic area in Taiwan Int J Epidemiol 34 2005 936 943 (Pubitemid 41418846)
6. W.P. Tseng Blackfoot disease in Taiwan: a 30-year follow-up study Angiology 40 1989 547 558
7. S.M. Tsai, T.N. Wang, and Y.C. Ko Mortality for certain diseases in areas with high levels of arsenic in drinking water Arch Environ Health 54 1999 186 193
8. K.P. Chen, H.Y. Wu, and T.C. Wu Epidemiologic studies on blackfoot disease in Taiwan. 3. Physicochemical characteristics of drinking water in endemic blackfoot disease areas Mem Coll Med Natl Taiwan Univ 8 1962 115 129
9. A.G. Mainous, R. Baker, R.J. Koopman, S. Saxena, V.A. Diaz, and C.J. Everett Impact of the population at risk of diabetes on projections of diabetes burden in the United States: an epidemic on the way Diabetologia 50 2007 934 940 (Pubitemid 46559242)
10. J.M. Lawrence, R. Contreras, W. Chen, and D.A. Sacks Trends in the prevalence of preexisting diabetes and gestational diabetes mellitus among a racially/ethnically diverse population of pregnant women, 1999-2005 Diabetes Care 31 2008 899 904
11. H. Kaneto, N. Katakami, D. Kawamori, T. Miyatsuka, K. Sakamoto, and T.A. Matsuoka Involvement of oxidative stress in the pathogenesis of diabetes Antioxid Redox Signal 9 2007 355 366 (Pubitemid 46145981)
12. K.A. Kim, and M.S. Lee Recent progress in research on beta-cell apoptosis by cytokines Front Biosci 14 2009 657 664
13. R.K. Campbell Type 2 diabetes: where we are today: an overview of disease burden, current treatments, and treatment strategies J Am Pharm Assoc 49 Suppl. 1 2009 S3 S9
14. M.S. Lai, Y.M. Hsueh, C.J. Chen, M.P. Shyu, S.Y. Chen, and T.L. Kuo Ingested inorganic arsenic and prevalence of diabetes mellitus Am J Epidemiol 139 1994 484 492
15. C.H. Tseng, C.P. Tseng, H.Y. Chiou, Y.M. Hsueh, C.K. Chong, and C.J. Chen Epidemiologic evidence of diabetogenic effect of arsenic Toxicol Lett 133 2002 69 76
16. M. Rahman, and O. Axelson Diabetes mellitus and arsenic exposure: a second look at case-control data from a Swedish copper smelter Occup Environ Med 52 1995 773 774
17. M. Rahman, M. Tondel, S.A. Ahmad, and O. Axelson Diabetes mellitus associated with arsenic exposure in Bangladesh Am J Epidemiol 148 1998 198 203 (Pubitemid 28334897)
18. D.R. Lewis Drinking water arsenic: the Millard County, Utah mortality study W.R. Chappell, C.O. Abernathy, R.L. Calderon, Arsenic exposure and health effects 1999 Elsevier New York 133 140
19. C.H. Tseng, C.K. Chong, L.T. Heng, C.P. Tseng, and T.Y. Tai The incidence of type 2 diabetes mellitus in Taiwan Diabetes Res Clin Pract 50 Suppl. 2 2000 S61 S64
20. C.H. Tseng, T.Y. Tai, C.K. Chong, C.P. Tseng, M.S. Lai, and B.J. Lin Long-term arsenic exposure and incidence of non-insulin-dependent diabetes mellitus: a cohort study in arseniasis-hyperendemic villages in Taiwan Environ Health Perspect 108 2000 847 851
21. S.L. Wang, J.M. Chiou, C.J. Chen, C.H. Tseng, W.L. Chou, and C.C. Wang Prevalence of non-insulin-dependent diabetes mellitus and related vascular diseases in southwestern arseniasis-endemic and nonendemic areas in Taiwan Environ Health Perspect 111 2003 155 159
22. A.H. Nabi, M.M. Rahman, and L.N. Islam Evaluation of biochemical changes in chronic arsenic poisoning among Bangladeshi patients Int J Environ Res Public Health 2 2005 385 393 (Pubitemid 47618947)
23. J.A. Coronado-Gonzalez, L.M. Del Razo, G. Garcia-Vargas, F. Sanmiguel-Salazar, and J. Escobedo-de la Peña Inorganic arsenic exposure and type 2 diabetes mellitus in Mexico Environ Res 104 2007 383 389 (Pubitemid 46856360)
24. A. Navas-Acien, E.K. Silbergeld, R. Pastor-Barriuso, and E. Guallar Arsenic exposure and prevalence of type 2 diabetes in US adults JAMA 300 2008 814 822
25. H.F. Chiu, C.C. Chang, S.S. Tsai, and C.Y. Yang Does arsenic exposure increase the risk for diabetes mellitus? J Occup Environ Med 48 2006 63 67
26. M. Rahman, G. Wingren, and O. Axelson Diabetes mellitus among Swedish art glass workers - an effect of arsenic exposure? Scand J Work Environ Health 22 1996 146 149 (Pubitemid 26151167)
27. A. Navas-Acien, E.K. Silbergeld, R.A. Streeter, J.M. Clark, T.A. Burke, and E. Guallar Arsenic exposure and type 2 diabetes: a systematic review of the experimental and epidemiological evidence Environ Health Perspect 114 2006 641 648
28. C.J. Chen, S.L. Wang, J.M. Chiou, C.H. Tseng, H.Y. Chiou, and Y.M. Hsueh Arsenic and diabetes and hypertension in human populations: a review Toxicol Appl Pharmacol 222 2007 298 304
29. M.L. Kile, and D.C. Christiani Environmental arsenic exposure and diabetes JAMA 300 2008 845 846
30. M.P. Longnecker, and J.L. Daniels Environmental contaminants as etiologic factors for diabetes Environ Health Perspect 109 Suppl. 6 2001 871 876 (Pubitemid 34055926)
31. Y. Chen, H. Ahsan, V. Slavkovich, G.L. Peltier, R.T. Gluskin, and F. Parvez No association between arsenic exposure from drinking water and diabetes mellitus: a cross-sectional study in Bangladesh Environ Health Perspect 118 2010 1299 1305
32. A. Consoli, N. Nurjhan, J.J. Reilly, D.M. Bier, and J.E. Gerich Mechanism of increased gluconeogenesis in noninsulin-dependent diabetes mellitus. Role of alterations in systemic, hepatic, and muscle lactate and alanine metabolism J Clin Invest 86 1990 2038 2045
33. P. Maechler, and C.B. Wollheim Mitochondrial function in normal and diabetic β-cells Nature 414 2001 807 812 (Pubitemid 34000784)
34. P.E. MacDonald, and M.B. Wheeler Voltage-dependent K(+) channels in pancreatic beta cells: role, regulation and potential as therapeutic targets Diabetologia 46 2003 1046 1062 (Pubitemid 37041235)
35. M. Tiedge, S. Lortz, J. Drinkgern, and S. Lenzen Relation between antioxidant enzyme gene expression and antioxidative defense status of insulin-producing cells Diabetes 46 1997 1733 1742 (Pubitemid 27456404)
36. S. Krauss, C.Y. Zhang, L. Scorrano, L.T. Dalgaard, J. St-Pierre, and S.T. Grey Superoxide-mediated activation of uncoupling protein 2 causes pancreatic β cell dysfunction J Clin Invest 112 2003 1831 1842 (Pubitemid 38063706)
37. A. Diaz-Villasenor, M.C. Sanchez-Soto, M.E. Cebrian, P. Ostrosky-Wegman, and M. Hiriart Sodium arsenite impairs insulin secretion and transcription in pancreatic β-cells Toxicol Appl Pharmacol 214 2006 30 34 (Pubitemid 43870369)
38. A. Diaz-Villasenor, A.L. Burns, A.M. Salazar, M. Sordo, M. Hiriart, and M.E. Cebrián Arsenite reduces insulin secretion in rat pancreatic beta-cells by decreasing the calcium-dependent calpain-10 proteolysis of SNAP-25 Toxicol Appl Pharmacol 231 2008 291 299
39. C.C. Yen, F.J. Lu, C.F. Huang, W.K. Chen, S.H. Liu, and S.Y. Lin-Shiau The diabetogenic effects of the combination of humic acid and arsenic: in vitro and in vivo studies Toxicol Lett 172 2007 91 105
40. J. Fu, C.G. Woods, E. Yehuda-Shnaidman, Q. Zhang, V. Wong, and S. Collins Low-level arsenic impairs glucose-stimulated insulin secretion in pancreatic beta cells: involvement of cellular adaptive response to oxidative stress Environ Health Perspect 118 2010 864 870
41. J. Scott, A. Opejin, A. Tidball, N. Stehouwer, J. Rekman, and L.L. Louters Dual action of phenylarsine oxide on the glucose transport activity of GLUT1 Chem Biol Interact 182 2009 199 203
42. D.S. Paul, A.W. Harmon, V. Devesa, D.J. Thomas, and M. Stýblo Molecular mechanisms of the diabetogenic effects of arsenic: inhibition of insulin signaling by arsenite and methylarsonous acid Environ Health Perspect 115 2007 734 742 (Pubitemid 46785043)
43. Y.P. Yen, K.S. Tsai, Y.W. Chen, C.F. Huang, R.S. Yang, and S.H. Liu Arsenic inhibits myogenic differentiation and muscle regeneration Environ Health Perspect 118 2010 949 956
44. S. Pal, and A.K. Chatterjee Prospective protective role of melatonin against arsenic-induced metabolic toxicity in Wistar rats Toxicology 208 2005 25 33 (Pubitemid 40143325)
45. J.A. Izquierdo-Vega, C.A. Soto, L.C. Sanchez-Pena, A. De Vizcaya-Ruiz, and L.M. Del Razo Diabetogenic effects and pancreatic oxidative damage in rats subchronically exposed to arsenite Toxicol Lett 160 2006 135 142 (Pubitemid 41578957)
46. M.D. Pysher, J.J. Sollome, S. Regan, T.R. Cardinal, J.B. Hoying, and H.L. Brooks Increased hexokinase II expression in the renal glomerulus of mice in response to arsenic Toxicol Appl Pharmacol 224 2007 39 48 (Pubitemid 47404619)
47. D.S. Paul, A. Hernandez-Zavala, F.S. Walton, B.M. Adair, J. Dedina, and T. Matousek Examination of the effects of arsenic on glucose homeostasis in cell culture and animal studies: development of a mouse model for arsenic-induced diabetes Toxicol Appl Pharmacol 222 2007 305 314 (Pubitemid 47198280)
48. D.S. Paul, V. Devesa, A. Hernandez-Zavala, B.M. Adair, F.S. Walton, and Z. Drobnâ Environmental arsenic as a disruptor of insulin signaling Met Ions Biol Med 10 2008 1 7
49. D.S. Hill, B.J. Wlodarczyk, L.E. Mitchell, and R.H. Finnell Arsenate-induced maternal glucose intolerance and neural tube defects in a mouse model Toxicol Appl Pharmacol 239 2009 29 36
50. A.R. Saltiel, and C.R. Kahn Insulin signalling and the regulation of glucose and lipid metabolism Nature 414 2001 799 806 (Pubitemid 34000783)
51. Y.W. Chen, C.Y. Yang, C.F. Huang, D.Z. Hung, Y.M. Leung, and S.H. Liu Heavy metals and islet function and diabetes development Islets 1 2009 169 176
52. F.S. Walton, A.W. Harmon, D.S. Paul, Z. Drobná, Y.M. Patel, and M. Styblo Inhibition of insulin-dependent glucose uptake by trivalent arsenicals: possible mechanism of arsenic-induced diabetes Toxicol Appl Pharmacol 198 2004 424 433 (Pubitemid 38969972)
53. A.G. Douen, and M.N. Jones The action of phenylarsine oxide on the stereospecific uptake of D-glucose in basal and insulin-stimulated rat adipocytes Biochim Biophys Acta 968 1988 109 118 (Pubitemid 18030317)
54. S.C. Frost, and M.D. Lane Evidence for the involvement of vicinal sulfhydryl groups in insulin-activated hexose transport by 3T3-L1 adipocytes J Biol Chem 260 1985 2646 2652 (Pubitemid 15139315)
55. S.C. Frost, R.A. Kohanski, and M.D. Lane Effect of phenylarsine oxide on insulin-dependent protein phosphorylation and glucose transport in 3T3-L1 adipocytes J Biol Chem 262 1987 9872 9876
56. N. Begum Phenylarsine oxide inhibits insulin-stimulated protein phosphatase 1 activity and GLUT-4 translocation Am J Physiol 267 1994 E14 E23
57. B.H. Jhun, J.S. Hah, and C.Y. Jung Phenylarsine oxide causes an insulin-dependent, GLUT4-specific degradation in rat adipocytes J Biol Chem 266 1991 22260 22265 (Pubitemid 21908644)
58. M. Bazuine, F. Carlotti, M.J. Rabelink, J. Vellinga, R.C. Hoeben, and J.A. Maassen The p38 mitogen-activated protein kinase inhibitor SB203580 reduces glucose turnover by the glucose transporter-4 of 3T3-L1 adipocytes in the insulin-stimulated state Endocrinology 146 2005 1818 1824 (Pubitemid 40396891)
59. R. Somwar, S. Koterski, G. Sweeney, R. Sciotti, S. Djuric, and C. Berg A dominant-negative p38 MAPK mutant and novel selective inhibitors of p38 MAPK reduce insulin-stimulated glucose uptake in 3T3-L1 adipocytes without affecting GLUT4 translocation J Biol Chem 277 2002 50386 50395 (Pubitemid 36042189)
60. M.M. Hill, S.F. Clark, D.F. Tucker, M.J. Birnbaum, D.E. James, and S.L. Macaulay A role for protein kinase Bbeta/Akt2 in insulin-stimulated GLUT4 translocation in adipocytes Mol Cell Biol 19 1999 7771 7781 (Pubitemid 29493441)
61. Q. Wang, R. Somwar, P.J. Bilan, Z. Liu, J. Jin, and J.R. Woodgett Protein kinase B/Akt participates in GLUT4 translocation by insulin in L6 myoblasts Mol Cell Biol 19 1999 4008 4018 (Pubitemid 29241975)
62. M. Bazuine, F. Carlotti, R.S. Tafrechi, R.C. Hoeben, and J.A. Maassen Mitogen-activated protein kinase (MAPK) phosphatase-1 and -4 attenuate p38 MAPK during dexamethasone-induced insulin resistance in 3T3-L1 adipocytes Mol Endocrinol 18 2004 1697 1707 (Pubitemid 38859577)
63. M. Bazuine, D.M. Ouwens, D.S. Gomes de Mesquita, and J.A. Maassen Arsenite stimulated glucose transport in 3T3-L1 adipocytes involves both Glut4 translocation and p38 MAPK activity Eur J Biochem 270 2003 3891 3903 (Pubitemid 37193866)
64. G.W. Gould, G.E. Lienhard, L.I. Tanner, and E.M. Gibbs Phenylarsine oxide stimulates hexose transport in 3T3-L1 adipocytes by a mechanism other than an increase in surface transporters Arch Biochem Biophys 268 1989 264 275 (Pubitemid 19038259)
65. H.E. McDowell, T. Walker, E. Hajduch, G. Christie, I.H. Batty, and C.P. Downes Inositol phospholipid 3-kinase is activated by cellular stress but is not required for the stress-induced activation of glucose transport in L6 rat skeletal muscle cells Eur J Biochem 247 1997 306 313 (Pubitemid 27319518)
66. C. Fladeby, and G. Serck-Hanssen Stress-induced glucose uptake in bovine chromaffin cells: a comparison of the effect of arsenite and anisomycin Biochim Biophys Acta 1452 1999 313 321
67. K. Souza, D.A. Maddock, Q. Zhang, J. Chen, C. Chiu, and S. Mehta Arsenite activation of P13K/AKT cell survival pathway is mediated by p38 in cultured human keratinocytes Mol Med 7 2001 767 772 (Pubitemid 34175298)
68. M.V. Aguilar, M.C. Martinez-Para, and M.J. Gonzalez Effects of arsenic (V)-chromium (III) interaction on plasma glucose and cholesterol levels in growing rats Ann Nutr Metab 41 1997 189 195 (Pubitemid 27384874)
69. L.L. Arnold, M. Eldan, M. van Gemert, C.C. Capen, and S.M. Cohen Chronic studies evaluating the carcinogenicity of monomethylarsonic acid in rats and mice Toxicology 190 2003 197 219 (Pubitemid 36966706)
70. U. Biswas, S. Sarkar, M.K. Bhowmik, A.K. Samanta, and S. Biswas Chronic toxicity of arsenic in goats: clinicobiochemical changes, pathomorphology and tissue residues Small Rumin Res 38 2000 229 235
71. 3+ to male Wistar rats Nutrition 13 1997 965 970
72. T. Ghafghazi, J.W. Ridlington, and B.A. Fowler The effects of acute and subacute sodium arsenite administration on carbohydrate metabolism Toxicol Appl Pharmacol 55 1980 126 130 (Pubitemid 10036699)
73. S. Pal, and A.K. Chatterjee Protective effect of N-acetylcysteine against arsenic-induced depletion in vivo of carbohydrate Drug Chem Toxicol 27 2004 179 189 (Pubitemid 38679577)